ESC Premium Access study - A randomized controlled trial evaluating the effectiveness of percutaneous mitral valve repair in secondary mitral regurgitation and reduced left ventricular ejection fraction

Topic: Mitral Valve Regurgitation

Congress Presentation

About the speaker

Professor Jean-Francois Obadia

Civils Hospices of Lyon, Lyon (France)
9 presentations
0 follower

19 more presentations in this session

Opening question - ATTR-ACT Trial.


ATTR-ACT Trial - Efficacy and Safety of Tafamidis in Transthyretin Amyloid Cardiomyopathy

Speaker: Professor C. Rapezzi (Ferrara, IT)


Discussant review - ATTR-ACT.

Speaker: Professor J. George (Rehovot, IL)


Questions from the audience and discussion.


Concluding question - ATTR-ACT Trial.


Access the full session

Hot Line Session 3

Speakers: Professor J. Obadia, Professor C. Rapezzi, Professor J. George

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb